Growing community of inventors

Groton, CT, United States of America

Benjamin A Thuma

Average Co-Inventor Count = 4.52

ph-index = 6

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 60

Benjamin A ThumaSpiros Liras (6 patents)Benjamin A ThumaVincent Mascitti (6 patents)Benjamin A ThumaKentaro Futatsugi (5 patents)Benjamin A ThumaKim Huard (5 patents)Benjamin A ThumaMeihua Mike Tu (5 patents)Benjamin A ThumaMatthew Scott Dowling (5 patents)Benjamin A ThumaThomas V Magee (5 patents)Benjamin A ThumaBrian Kenneth Raymer (5 patents)Benjamin A ThumaAaron Smith (5 patents)Benjamin A ThumaDilinie Fernando (5 patents)Benjamin A ThumaAndy Tsai (5 patents)Benjamin A ThumaAndre Shavnya (5 patents)Benjamin A ThumaJennifer A Doudna (1 patent)Benjamin A ThumaRoger B Ruggeri (1 patent)Benjamin A ThumaGeorge T Magnus-Aryitey (1 patent)Benjamin A ThumaRomain Rouet (1 patent)Benjamin A ThumaBenjamin A Thuma (12 patents)Spiros LirasSpiros Liras (18 patents)Vincent MascittiVincent Mascitti (11 patents)Kentaro FutatsugiKentaro Futatsugi (29 patents)Kim HuardKim Huard (21 patents)Meihua Mike TuMeihua Mike Tu (19 patents)Matthew Scott DowlingMatthew Scott Dowling (18 patents)Thomas V MageeThomas V Magee (18 patents)Brian Kenneth RaymerBrian Kenneth Raymer (13 patents)Aaron SmithAaron Smith (12 patents)Dilinie FernandoDilinie Fernando (11 patents)Andy TsaiAndy Tsai (8 patents)Andre ShavnyaAndre Shavnya (5 patents)Jennifer A DoudnaJennifer A Doudna (138 patents)Roger B RuggeriRoger B Ruggeri (40 patents)George T Magnus-AryiteyGeorge T Magnus-Aryitey (7 patents)Romain RouetRomain Rouet (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Pfizer Corporation (12 from 4,455 patents)

2. University of California (1 from 15,458 patents)


12 patents:

1. 11634410 - Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors

2. 10988463 - Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors

3. 10851367 - Tissue-specific genome engineering using CRISPR-Cas9

4. 10813942 - Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR

5. 10787438 - Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors

6. 10376531 - Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR

7. 10174007 - Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors

8. 10039778 - Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR

9. 9809579 - Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors

10. 9617293 - Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR

11. 9340553 - Substituted-6,8-dioxabicyclo[3.2.1]octane-2,3-diol compounds as targeting agents of ASGPR

12. 7615651 - Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…